Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05580588
Title Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shanghai Pharma Biotherapeutics USA Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.